Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net loss	$ (23,828)	$ (69,400)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,222	3,987
Amortization and impairment of internal-use software	1,846	1,799
Stock-based compensation expense	5,711	21,577
Loss (gain) on disposal of property and equipment	76	(44)
Gain on liabilities subject to compromise	(43,093)	0
Reorganization items	35,786	0
Changes in operating assets and liabilities:
Accounts receivable, net	126	2,226
Inventories	2,141	(2,283)
Deferred cost of revenue	(800)	(254)
Prepaid expenses and other current assets	6,010	378
Operating lease right-of-use assets	82	1,878
Other assets	178	728
Accounts payable (includes related party amounts of $2,237 and $1,062 for the three months ended June 30, 2025 and 2024, respectively)	6,265	(309)
Accrued expenses and other current liabilities (includes related party amounts of $(2,255) and $(4,300) for the three months ended June 30, 2025 and 2024, respectively)	(6,706)	581
Deferred revenue (includes related party amounts of $(235) and $(181) for the three months ended June 30, 2025 and 2024, respectively)	(8,290)	(1,812)
Operating lease liabilities	(6,719)	(2,351)
Other liabilities	0	29
Net cash used in operating activities	(28,993)	(43,270)
Cash flows from investing activities:
Purchases of property and equipment	(42)	(366)
Proceeds from sale of property and equipment	0	148
Capitalized internal-use software costs	(991)	(938)
Net cash used in investing activities	(1,033)	(1,156)
Cash flows from financing activities:
Proceeds from DIP financing	25,000	0
Proceeds from exercise of stock options	0	58
Payments of deferred offering costs	0	(1)
Payments for taxes related to net share settlement of equity awards	(217)	(48)
Payments of DIP financing fees	(500)	0
Net cash provided by financing activities	24,283	9
Net decrease in cash, cash equivalents and restricted cash	(5,743)	(44,417)
Cash, cash equivalents and restricted cash—beginning of period	51,294	224,861
Cash, cash equivalents and restricted cash—end of period	45,551	180,444
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses	0	111
Stock-based compensation capitalized for internal-use software costs	524	414
Unpaid settlement of employee equity awards included in accrued expenses	3,631	0
Reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	39,828	169,971
Restricted cash, current	423	1,499
Restricted cash, noncurrent	5,300	8,974
Total cash, cash equivalents and restricted cash	$ 45,551	$ 180,444